% | $
Quotes you view appear here for quick access.

Trius Therapeutics, AŞ Message Board

  • manakawari manakawari Jan 29, 2012 1:36 PM Flag

    nice little set up

    low volume on support suggests selling is over. closed on a doji on a red day further suggest selling is over.short interest has also fallen to levels that sparked a 50 percent spike in a few days in the past.dilution was predicted weeks ago, combined with single large fund profit taking last week, it seems that the market has priced in dilution and then some.chart is hot hot hot and looks locked and loaded.
    also here is a short interest chart. when selling is over there is only one direction to go.
    seems like the biggest fear in biotech is dilution and bad results/decisions.we have our dilution priced in, now cash rich with good trial results and very low approval risk.low price tag with product that will compete with a couple billion dollar product that shows superiority on several levels, in a time where competitors patent is running out in a few months. to me, that tells me that tsrx is primed for a buy out by big pharma so they may hold that huge market share. our drug is just as effective with more convenient dosing and tolerance. seems like this is exactly what pfizer needs to convince doctors to switch to this instead of their soon to be generic me, based on perfect storm recently to depress share price/wonderful chart/action to suggest bounce and timing of potential buyout. i cant see anywhere to go but up..i welcome suggestions or concerns. thanks!

    SortNewest  |  Oldest  |  Most Replied Expand all replies